Y. Takikawa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Y Takikawa, Y. Takikawa, Yasuhiro Takikawa
Publication record
259 papers · 5,624 citations · H-index 36

PAPERS

Comparative analysis of sorafenib and lenvatinib on HepG2 cells and human umbilical vein endothelial cells: Involvement of transforming growth factor‐β signaling in their molecular effects
20242 citationsauthor #2
Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation
20240 citationsauthor #8
Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study
20238 citationsauthor #5
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
202211 citationsauthor #15
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan
20225 citationsauthor #7
Diagnostic criteria for acute‐on‐chronic liver failure and related disease conditions in Japan
202221 citationsauthor #9
Evaluation of SOX9-Positive Hepatocytes in Human Liver Specimens and Mature Mouse Hepatocytes.
20221 citationsauthor #5
Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
20226 citationsauthor #7
The impact of liver function improvement after direct-acting antiviral therapy on the outcome in hepatitis C virus patients with decompensated cirrhosis
20220 citationsauthor #10
Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease
20229 citationsauthor #5
Viral eradication by direct-acting antivirals does not decrease the serum myostatin level in patients infected with hepatitis C virus.
20222 citationsauthor #6
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
202236 citationsauthor #19
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
202211 citationsauthor #15
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
202232 citationsauthor #10
Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement
202211 citationsauthor #5
The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features
20224 citationsauthor #7
Referral system has a diminished difference in the risk for hepatic encephalopathy development among each etiology in patients with acute liver injury
20227 citationsauthor #4
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
202214 citationsauthor #18
Excess fructose enhances oleatic cytotoxicity via reactive oxygen species production and causes necroptosis in hepatocytes.
202210 citationsauthor #7
Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization
202112 citationsauthor #10
A 51-Year-Old Woman with Drug-Induced Hypersensitivity Syndrome Associated with Carbamazepine, Reactivation of Human Herpesvirus 6, and Acute Liver Failure: A Case Report
20213 citationsauthor #4
Appropriate information provision about COVID-19 and SARS-CoV-2 vaccine improves vaccination anxiety in patients with autoimmune liver disease
20210 citationsauthor #4
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria
202113 citationsauthor #14
Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines
20214 citationsauthor #19
Acute Liver Injury Due to T-cell Infiltration into the Liver as an Initial Clinical Finding of Adult T-cell Leukemia/Lymphoma
20210 citationsauthor #5
Acute liver failure precipitated by acute Budd‐Chiari syndrome and complete portal vein thrombosis
20214 citationsauthor #4
Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy
20213 citationsauthor #8
Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
20215 citationsauthor #4
Supplementation with Branched-Chain Amino Acids Induces Unexpected Deleterious Effects on Astrocyte Survival and Intracellular Metabolism with or without Hyperammonemia: A Preliminary In Vitro Study
20211 citationsauthor #5
Serum alpha-fetoprotein increases prior to fibrosis resolution in a patient with acute liver failure
20211 citationsauthor #6
Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
202132 citationsauthor #8
Predictive scoring system for advanced liver fibrosis in Japanese patients with severe obesity
20215 citationsauthor #10
Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury
20213 citationsauthor #7
Comparing the Safety and Efficacy of Microwave Ablation Using ThermosphereTM Technology versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
202111 citationsauthor #10
High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity
202110 citationsauthor #9
Letter to the editor: Autoimmune hepatitis after COVID‐19 vaccination: Need for population‐based epidemiological study
202121 citationsauthor #3
A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report
20211 citationsauthor #4
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study
202126 citationsauthor #34
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis
202141 citationsauthor #76
Information-Sharing Reduces Anxiety Towards Vaccines for SARS-CoV-2 in Patients With Autoimmune Liver Disease
20210 citationsauthor #6
Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease
202126 citationsauthor #5
A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination
20215 citationsauthor #5
Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late‐onset hepatic failure in Japan
20214 citationsauthor #7
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
202139 citationsauthor #38
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
202060 citationsauthor #6
[Acute liver failure:prediction and prevention].
20200 citationsauthor #2
A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection
20203 citationsauthor #6
Persistent Elevation of Serum Prothrombin Induced by Vitamin K Deficiency or Antagonist Despite Discontinuation of Warfarin Administration in Alcoholic Cirrhosis in The Absence of Hepatocellular Carcinoma: A Case Report
20200 citationsauthor #6
Practical guide on on-line hemodiafiltration for acute liver failure
20201 citationsauthor #4
Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury
20206 citationsauthor #7
Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
202018 citationsauthor #7
Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease
202029 citationsauthor #4
Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
202031 citationsauthor #11
ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis
202015 citationsauthor #8
Calf circumference as an easy surrogate marker for the screening of Japanese patients with chronic liver disease
20200 citationsauthor #4
Difference in seroprevalence of IgG antibodies against hepatitis A virus on general population in 1998 and 2019 in Iwate Prefecture, Japan
20200 citationsauthor #4
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
202015 citationsauthor #27
Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin
20203 citationsauthor #6
Multicenter study on the consciousness‐regaining effect of a newly developed artificial liver support system in acute liver failure: An on‐line continuous hemodiafiltration system
202010 citationsauthor #1
Sustained virologic response by direct‐acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection
202012 citationsauthor #7
Circular microRNA profiles as biomarkers for early stage hepatocellular carcinoma in patients infected with hepatitis B virus: a pair-matched case-control study
20201 citationsauthor #3
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
202047 citationsauthor #10
Response to the letter by Sumida et al. regarding our manuscript “Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease”
20190 citationsauthor #9
A Lille model for predicting the response of severe alcoholic hepatitis to corticosteroid treatment in Japanese patients
20195 citationsauthor #9
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey
201989 citationsauthor #6
Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
201913 citationsauthor #9
SAT-228-Sustained virologic response induced by direct-acting antivirals suppresses skeletal muscle loss in patients with type C liver disease
20190 citationsauthor #4
IL‐8 induces transdifferentiation of mature hepatocytes toward the cholangiocyte phenotype
201910 citationsauthor #9
FRI-493-Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocelluar carcinoma
20191 citationsauthor #3
Lenvatinib treatment for advanced hepatocellular carcinoma: The relationship between efficacy and safety
20190 citationsauthor #10
Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis
201995 citationsauthor #25
Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination
201923 citationsauthor #4
Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
201916 citationsauthor #7
FRI-096-Technetium-99m-GSA within the first 3d after admission as an early predictor of outcome in severe acute liver injury
20190 citationsauthor #7
Unfavorable prognosis of patients with acute liver injury due to drug‐induced liver injury and acute exacerbation of hepatitis B virus infection
201912 citationsauthor #9
Hepatic Encephalopathy in Liver Cirrhosis
20190 citationsauthor #1
Disease severity of acute liver injury caused by drug‐induced liver injury may affect the response to corticosteroid therapy
20192 citationsauthor #3
Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
201930 citationsauthor #10
Therapeutic Strategies and Current Management for Hepatic Encephalopathy in Liver Cirrhosis
20191 citationsauthor #3
Conservative Treatment: Nutritional Treatment
20190 citationsauthor #2
A multicenter pilot survey to clarify the clinical features of patients with acute‐on‐chronic liver failure in Japan
201827 citationsauthor #8
Orthotopic liver transplantation for haemophilia A may not always lead to a phenotypic cure of haemophilia A: A case report
20185 citationsauthor #7
Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine
201856 citationsauthor #12
The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1
20184 citationsauthor #11
Proposed diagnostic criteria for acute‐on‐chronic liver failure in Japan
201835 citationsauthor #6
Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
201897 citationsauthor #8
Nationwide survey for acute liver failure and late-onset hepatic failure in Japan
201870 citationsauthor #8
The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients
20183 citationsauthor #6
Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma
20189 citationsauthor #5
Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease
201824 citationsauthor #9
Liver Regeneration Supported by Muse Cells.
20182 citationsauthor #4
Accuracy of 2D shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis C
201829 citationsauthor #7
Predictive formula of coma onset and prothrombin time to distinguish patients who recover from acute liver injury
201811 citationsauthor #7
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial
201836 citationsauthor #3
Occurrence of hepatocellular carcinoma 24 years after successful interferon therapy in a patient with chronic hepatitis C: a case report
20185 citationsauthor #12
Association of therapeutic management with a good prognosis in unresectable hepatocellular carcinoma patients undergoing sorafenib treatment: Dose adjustment and conversion therapy.
20180 citationsauthor #5
Changes in pulmonary function of residents in Sanriku Seacoast following the tsunami disaster from the Great East Japan Earthquake.
20186 citationsauthor #6
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
2018126 citationsauthor #9
Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug‐induced liver injury by direct acting antivirals
201823 citationsauthor #7
L‐carnitine prevents ammonia‐induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytes
201816 citationsauthor #6

TIMELINE

1985 1 citations

1987 1 citations

1991 6 citations

1992 35 citations

1993 6 citations

1995 0 citations

1996 3 citations

1997 16 citations

1998 14 citations

1999 87 citations

2000 7 citations

2001 193 citations

2002 331 citations

2003 3 citations

2004 144 citations

2005 15 citations

2006 51 citations

2007 137 citations

2008 30 citations

2009 1,182 citations

2010 108 citations

2011 234 citations

2012 238 citations

2013 269 citations

2014 310 citations

2015 85 citations

2016 288 citations

2017 110 citations

2018 720 citations

2019 297 citations

2020 251 citations

2021 270 citations

2022 180 citations

2023 8 citations

2024 2 citations

Y. Takikawa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT